Dr. Mukund Chorghade
Dr. Chorghade has conducted more than 27 years of research leadership and project management for several multi-million dollar projects. His varied expertise ranges from organic synthesis enzymes, carbohydrates, heterocycles, natural products and molecular recognition. Dr. Chorghade has worked with numerous chemists and has been elected to fellowships in many prestigious academic societies. He has served as President and Chief Scientific Officer at Thinq Pharma/Thinq Drug DiscoveryThinq Pharma-CRO since 2006. Prior to his current role, Dr. Chorghade was the Vice President of Pharmaceutical Development Sciences and a Member of the Corporate Steering Committee at Genzyme Corporation. He has received the prestigious Henry A. Hill Award for Outstanding Contributions to NESACS.
He gained further experience serving as Senior Director of Chemical Sciences Research and Development at Cytomed, a Project Manager and Research Investigator at Abbott Laboratories, a Research Scientist and Assistant Director of College de France and a Project Leader at Dow Chemical. Dr. Chorghade was also a Postdoctoral Research Fellow at Harvard University, a Postdoctoral Research Associate at the University of Virginia and an Instructor at Georgetown University.